---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-08T20:24:47.788984'
end_time: '2026-02-08T20:30:33.971059'
duration_seconds: 346.18
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: SFT2D3
  gene_symbol: SFT2D3
  uniprot_accession: Q587I9
  protein_description: 'RecName: Full=Vesicle transport protein SFT2C; AltName: Full=SFT2
    domain-containing protein 3;'
  gene_info: Name=SFT2D3 {ECO:0000312|HGNC:HGNC:28767};
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the SFT2 family. .
  protein_domains: Vesicle_transpt_Got1/SFT2. (IPR007305); Vesicle_transpt_SFT2. (IPR011691);
    Got1 (PF04178)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 14
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q587I9
- **Protein Description:** RecName: Full=Vesicle transport protein SFT2C; AltName: Full=SFT2 domain-containing protein 3;
- **Gene Information:** Name=SFT2D3 {ECO:0000312|HGNC:HGNC:28767};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the SFT2 family. .
- **Key Domains:** Vesicle_transpt_Got1/SFT2. (IPR007305); Vesicle_transpt_SFT2. (IPR011691); Got1 (PF04178)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "SFT2D3" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'SFT2D3' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **SFT2D3** (gene ID: SFT2D3, UniProt: Q587I9) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q587I9
- **Protein Description:** RecName: Full=Vesicle transport protein SFT2C; AltName: Full=SFT2 domain-containing protein 3;
- **Gene Information:** Name=SFT2D3 {ECO:0000312|HGNC:HGNC:28767};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the SFT2 family. .
- **Key Domains:** Vesicle_transpt_Got1/SFT2. (IPR007305); Vesicle_transpt_SFT2. (IPR011691); Got1 (PF04178)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "SFT2D3" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'SFT2D3' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **SFT2D3** (gene ID: SFT2D3, UniProt: Q587I9) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and verification
- Identity: The target is SFT2D3 (SFT2 domain-containing protein 3; alias SFT2C), UniProt Q587I9, a human multi-pass membrane protein in the SFT2/GOT1 family. Organism: Homo sapiens. Domains: SFT2/GOT1 family signatures (IPR007305, IPR011691; PF04178). This matches the provided UniProt context and all retrieved literature items that explicitly name SFT2D3 as a vesicle transport-related gene. No conflicting human gene symbol usage was found in our sources. (liu2020atranscriptomewideassociation pages 6-8)

Executive summary
Direct, human experimental literature specific to SFT2D3 remains sparse; however, convergent evidence supports that SFT2D3 is a membrane protein associated with Golgi trafficking vesicles, likely acting in endosome-to-Golgi or intra-Golgi pathways in concert with SNARE/tether machinery. Evidence includes: (i) 2024 Golgi-vesicle proteomics that detected SFT2D3 as enriched in intra-Golgi vesicles, (ii) strong ortholog data from yeast Sft2 showing a SNARE-associated role in late-Golgi/TGN SNARE recycling under ER stress, and (iii) expert reviews detailing the tether/SNARE context (GARP and COG) through which SFT2-family proteins are typically considered. A 2020 TWAS nominated SFT2D3 as a vesicle-fusion–related gene associated with pancreatic cancer susceptibility. Together, these support a working model that human SFT2D3 is a Golgi/endosomal pathway multipass membrane factor that tunes SNARE recycling and vesicle traffic at the TGN/late Golgi, with translational signals emerging in cancer genetics. (sumya2024comprehensiveproteomiccharacterization pages 37-39, lai2024thesnareassociatedprotein pages 7-11, khakurel2023roleofgarp pages 7-9, liu2020atranscriptomewideassociation pages 6-8)

1) Key concepts and definitions
- SFT2 family proteins: Small, predominantly multi-pass membrane proteins localized to the Golgi/endosomal system, initially characterized in yeast (Sft2p) for roles in vesicle trafficking and SNARE-associated recycling. Human SFT2D3 is one of several SFT2-domain proteins. In yeast, Sft2 is not a SNARE itself but associates functionally with SNARE machinery. (lai2024thesnareassociatedprotein pages 7-11)
- Golgi tethers and SNAREs: Endosome-to-TGN retrograde transport depends on multisubunit tethering complexes such as GARP, which cooperate with SNARE complexes (e.g., STX16/STX6/VTI1A/VAMP4) to ensure docking and fusion of endosome-derived vesicles at the TGN. Disruption of tethering impairs recycling of TGN proteins and destabilizes SNAREs. This context frames plausible roles for SFT2D3. Review, 2023-03-31 (IJMS). URL: https://doi.org/10.3390/ijms24076069 (khakurel2023roleofgarp pages 7-9)

2) Recent developments and latest research (2023–2024 prioritized)
- Golgi vesicle proteomics identifies SFT2D3: A 2024 proteomic dissection of vesicles from cis/medial/trans-Golgi compartments reported SFT2D3 as enriched (~12-fold) among Golgi-derived vesicle proteins, implicating it in the intra-Golgi vesicle recycling system and Golgi homeostasis. Preprint posted 2024-10-25 (bioRxiv). URL: https://doi.org/10.1101/2024.10.25.620336 (sumya2024comprehensiveproteomiccharacterization pages 37-39)
- Ortholog mechanistic advance: A 2024 Molecular Biology of the Cell study established that yeast Sft2p is a SNARE-associated protein required for Imh1-mediated recycling of SNAREs (e.g., Snc1/Tlg1) to the late Golgi/TGN during ER stress, refining prior models from “SNARE-like” to “SNARE-associated” and mapping dependencies on Tlg2/Imh1 for Sft2 targeting. Published 2024-10 (MBoC). URL: https://doi.org/10.1091/mbc.e23-01-0019 (lai2024thesnareassociatedprotein pages 14-17, lai2024thesnareassociatedprotein pages 7-11)
- Updated conceptual framework for tethers/SNAREs: A 2023 expert review synthesized new data on GARP as a central TGN tether coordinating endosome-to-Golgi trafficking via defined SNARE complexes; knockdown of GARP components reduces formation/stability of STX16/STX6/VTI1A/VAMP4 and affects intra-Golgi SNAREs (GOSR1/BET1L). Published 2023-03-31 (IJMS). URL: https://doi.org/10.3390/ijms24076069 (khakurel2023roleofgarp pages 7-9)

3) Current applications and real-world implementations
- Organelle proteomics pipelines: The 2024 Golgi-vesicle proteomic workflow provides an experimental route for detecting SFT2D3 in organelle-derived vesicles, enabling future assays of SFT2D3 dynamics under perturbations of tethers/SNAREs or stress. Posted 2024-10-25 (bioRxiv). URL: https://doi.org/10.1101/2024.10.25.620336 (sumya2024comprehensiveproteomiccharacterization pages 37-39)
- Pathway inference for secretory stress responses: The yeast findings position SFT2-family proteins within ER-stress–responsive Golgi recycling circuits, informing experimental designs in human cells to test SFT2D3 roles in maintaining exocytic competence and SNARE availability under stress. Published 2024-10 (MBoC). URL: https://doi.org/10.1091/mbc.e23-01-0019 (lai2024thesnareassociatedprotein pages 7-11)

4) Expert opinions and analysis from authoritative sources
- Tether/SNARE axis: Expert synthesis indicates that GARP functions at the TGN by engaging coiled-coil tethers and endosome-to-Golgi SNARE complexes, coordinating vesicle docking/fusion and maintaining TGN protein recycling; deficits destabilize SNARE abundance and broaden trafficking defects. This supports evaluating SFT2D3 functionally in GARP/SNARE contexts. Published 2023-03-31 (IJMS). URL: https://doi.org/10.3390/ijms24076069 (khakurel2023roleofgarp pages 7-9)
- Ortholog-based mechanism: The 2024 yeast study argues that Sft2, while not itself a SNARE, acts as a SNARE-associated factor downstream of the Arl1–golgin Imh1 axis to recycle specific SNAREs during ER stress, a mechanistic motif likely conserved across eukaryotes. Published 2024-10 (MBoC). URL: https://doi.org/10.1091/mbc.e23-01-0019 (lai2024thesnareassociatedprotein pages 7-11)

5) Relevant statistics and data from recent studies
- Proteomic enrichment: SFT2D3 was reported enriched approximately 12-fold in Golgi-derived vesicles in a 2024 proteomics study, indicating strong association with Golgi vesicle intermediates. Posted 2024-10-25 (bioRxiv). URL: https://doi.org/10.1101/2024.10.25.620336 (sumya2024comprehensiveproteomiccharacterization pages 37-39)
- Genetic association: A TWAS implicating pancreatic cancer risk identified 13 genes at FDR ≤ 0.05, including SFT2D3 listed among vesicle-fusion–related genes; this nominates SFT2D3 for functional follow-up in pancreatic cancer biology. Published 2020-10 (Cancer Research). URL: https://doi.org/10.1158/0008-5472.CAN-20-1353 (liu2020atranscriptomewideassociation pages 6-8)

Detailed functional annotation for SFT2D3
(a) Molecular function and role in vesicle transport
- Strong inference from orthologs: Yeast Sft2 is a tetraspanning membrane protein that associates with SNARE machinery to mediate recycling of exocytic and late-Golgi SNAREs (Snc1, Tlg1) under ER stress via an Arl1–Imh1–Sft2 axis, thereby supporting vesicle fusion/exocytosis competence. By homology, human SFT2D3 is likely a multipass membrane factor that promotes SNARE recycling or availability at the TGN/late Golgi, indirectly enabling vesicle docking/fusion steps. Published 2024-10 (MBoC). URL: https://doi.org/10.1091/mbc.e23-01-0019 (lai2024thesnareassociatedprotein pages 7-11)
- Proteomic support in mammals: Enrichment of SFT2D3 in Golgi-derived vesicle proteomes (2024) suggests direct participation in intra-Golgi vesicle pathways, consistent with a role in SNARE/tether-associated recycling circuits rather than as a soluble enzyme. Posted 2024-10-25 (bioRxiv). URL: https://doi.org/10.1101/2024.10.25.620336 (sumya2024comprehensiveproteomiccharacterization pages 37-39)

(b) Subcellular localization
- Inference from orthologs and vesicle proteomics: Yeast Sft2 localizes to punctate late-Golgi/TGN membranes and cycles between endosomes and the late Golgi; dependency on Tlg2/Imh1 anchors its late-Golgi targeting. Human SFT2D3’s detection in Golgi-derived vesicles supports a similar Golgi/TGN and endosome-to-Golgi localization, though direct human imaging/localization evidence was not captured in our sources. Published 2024-10 (MBoC); posted 2024-10-25 (bioRxiv). URLs: https://doi.org/10.1091/mbc.e23-01-0019; https://doi.org/10.1101/2024.10.25.620336 (lai2024thesnareassociatedprotein pages 7-11, sumya2024comprehensiveproteomiccharacterization pages 37-39)

(c) Participation in endosome-to-Golgi or intra-Golgi pathways; relation to SNAREs/GARP/COG
- Endosome-to-TGN and intra-Golgi context: The 2023 review details GARP-dependent tethering at the TGN with canonical SNARE sets (STX16/STX6/VTI1A/VAMP4) and effects on intra-Golgi SNAREs (GOSR1/BET1L). Given yeast Sft2’s SNARE-associated recycling at late Golgi and the mammalian proteomic detection of SFT2D3 in Golgi vesicles, SFT2D3 likely functions at the interface of SNAREs and tethers in retrograde and/or intra-Golgi trafficking. Published 2023-03-31 (IJMS). URL: https://doi.org/10.3390/ijms24076069 (khakurel2023roleofgarp pages 7-9)
- Ortholog mechanistic tie-in: Sft2’s requirement for Imh1 (a golgin) and cooperation with GARP in yeast during ER stress suggests SFT2D3 may act with mammalian golgins and GARP/COG to maintain SNARE recycling and Golgi homeostasis, particularly under stress. Published 2024-10 (MBoC). URL: https://doi.org/10.1091/mbc.e23-01-0019 (lai2024thesnareassociatedprotein pages 7-11)

(d) Expression or detection in human proteomics
- Detected in Golgi-derived vesicles: A 2024 study profiling intra-Golgi trafficking intermediates reported SFT2D3 among enriched vesicular proteins (~12-fold), supporting its presence in mammalian Golgi vesicle fractions. Posted 2024-10-25 (bioRxiv). URL: https://doi.org/10.1101/2024.10.25.620336 (sumya2024comprehensiveproteomiccharacterization pages 37-39)

(e) Post-translational modifications (PTMs)
- No direct human PTM data: The gathered sources did not report mapped PTMs for human SFT2D3. Future targeted proteomics would be required to define acylation or phosphorylation status, which can be functionally important for multi-pass Golgi proteins. (sumya2024comprehensiveproteomiccharacterization pages 37-39, lai2024thesnareassociatedprotein pages 7-11)

(f) Disease associations from recent studies
- Pancreatic cancer susceptibility nomination: A 2020 TWAS of pancreatic cancer identified 13 genes with genetically predicted expression associated with risk (FDR ≤ 0.05), citing SFT2D3 as a vesicle-fusion–related gene among the nominated candidates, motivating disease-focused functional validation. Published 2020-10 (Cancer Research). URL: https://doi.org/10.1158/0008-5472.CAN-20-1353 (liu2020atranscriptomewideassociation pages 6-8)

Limitations and evidence grading
- Direct human functional studies on SFT2D3 remain limited in the accessible record. The strongest mechanistic evidence derives from the conserved yeast ortholog Sft2 under ER stress and from mammalian organelle proteomics. Therefore, assertions about specific SNARE partners or tether interactions for human SFT2D3 are inferences awaiting direct experimental confirmation in human systems. (sumya2024comprehensiveproteomiccharacterization pages 37-39, lai2024thesnareassociatedprotein pages 7-11)

Evidence map (concise)
| Aspect | Key finding | Species/Model | Method/Study type | Year | Source (full citation) | URL |
|---|---|---:|---|---:|---|---|
| Human Proteomics/Detection | SFT2D3 was detected as enriched (~12-fold) in Golgi-derived vesicle proteomes, suggesting association with intra-Golgi trafficking vesicles. | Mammalian cells (Golgi vesicle prep) | Golgi-derived vesicle proteomics (TMT/MS proteomics) | 2024 | Sumya FT, Aragon-Ramirez WS, Lupashin VV. Comprehensive Proteomic Characterization of the Intra-Golgi Trafficking Intermediates. bioRxiv. 2024. (sumya2024comprehensiveproteomiccharacterization pages 37-39) | https://doi.org/10.1101/2024.10.25.620336 |
| Function / Pathway (Ortholog evidence) | Yeast Sft2 is a multi-pass membrane, SNARE-associated factor required for Imh1-mediated SNARE (Snc1/Tlg1) recycling at the late-Golgi/TGN under ER stress, implying a role in SNARE recycling/tethering for SFT2 family proteins. | Saccharomyces cerevisiae | Genetic perturbation, fluorescence microscopy, trafficking assays | 2024 | Lai CC, Chiu WY, Chen YT, Wu CL, Lee FJS. The SNARE-associated protein Sft2 functions in Imh1-mediated SNARE recycling transport upon ER stress. Molecular Biology of the Cell. 2024. doi:10.1091/mbc.e23-01-0019. (lai2024thesnareassociatedprotein pages 7-11) | https://doi.org/10.1091/mbc.e23-01-0019 |
| Expert / Review context | GARP is an endosome-to-TGN tether that binds specific SNARE complexes (STX16/STX6/VTI1A/VAMP4) and affects SNARE abundance/stability; this review provides mechanistic context suggesting SFT2-family proteins could act with tethers and SNAREs in retrograde/intra-Golgi trafficking. | Review (mammalian + yeast literature) | Literature review / synthesis | 2023 | Khakurel A, Lupashin VV. Role of GARP Vesicle Tethering Complex in Golgi Physiology. International Journal of Molecular Sciences. 2023;24:6069. doi:10.3390/ijms24076069. (khakurel2023roleofgarp pages 7-9) | https://doi.org/10.3390/ijms24076069 |
| Disease / Clinical associations | SFT2D3 was nominated as a vesicle-fusion–related gene in a transcriptome-wide association study implicating genes in pancreatic cancer susceptibility. | Human (TWAS) | Transcriptome-wide association study (genetic association) | 2020 | Liu D, Zhou D, Sun Y, Zhu J, Ghoneim D, et al. A Transcriptome-Wide Association Study Identifies Candidate Susceptibility Genes for Pancreatic Cancer Risk. Cancer Research. 2020;80:4346-4354. doi:10.1158/0008-5472.CAN-20-1353. (liu2020atranscriptomewideassociation pages 6-8) | https://doi.org/10.1158/0008-5472.CAN-20-1353 |
| Localization (inference) | Localization is inferred to late-Golgi/TGN and endosome-to-Golgi recycling compartments based on yeast Sft2 cycling between endosomes and late-Golgi; no direct human subcellular localization data were provided in the gathered sources. | Inference from S. cerevisiae / SFT2 family | Ortholog-based inference; yeast imaging | 2024 (inference from 2024 yeast study) | Lai CC, Chiu WY, Chen YT, Wu CL, Lee FJS. The SNARE-associated protein Sft2 functions in Imh1-mediated SNARE recycling transport upon ER stress. Molecular Biology of the Cell. 2024. doi:10.1091/mbc.e23-01-0019. (lai2024thesnareassociatedprotein pages 7-11) | https://doi.org/10.1091/mbc.e23-01-0019 |
| Post-translational modifications (PTMs) | No direct human evidence for specific PTMs of SFT2D3 was found in the gathered sources (no PTM mapping reported). | Human (absence of data) | Proteomics / literature survey (negative finding) | 2024 (latest reviewed sources) | Sources report no human-specific PTM data for SFT2D3 in the surveyed literature (e.g., yeast study and proteomics review note lack of direct human PTM information). (lai2024thesnareassociatedprotein pages 7-11) | https://doi.org/10.1091/mbc.e23-01-0019 |


*Table: Concise table mapping key, source-traceable findings about human SFT2D3 (UniProt Q587I9) including proteomic detection, ortholog-supported function/localization, review context on tether/SNARE networks, TWAS disease nomination, and absence of reported human PTMs.*

References (URLs and dates)
- Sumya FT, Aragon-Ramirez WS, Lupashin VV. Comprehensive Proteomic Characterization of the Intra-Golgi Trafficking Intermediates. bioRxiv. Posted 2024-10-25. URL: https://doi.org/10.1101/2024.10.25.620336 (sumya2024comprehensiveproteomiccharacterization pages 37-39)
- Lai CC, Chiu WY, Chen YT, Wu CL, Lee FJS. The SNARE-associated protein Sft2 functions in Imh1-mediated SNARE recycling transport upon ER stress. Molecular Biology of the Cell. Published 2024-10. URL: https://doi.org/10.1091/mbc.e23-01-0019 (lai2024thesnareassociatedprotein pages 14-17, lai2024thesnareassociatedprotein pages 7-11)
- Khakurel A, Lupashin VV. Role of GARP Vesicle Tethering Complex in Golgi Physiology. International Journal of Molecular Sciences. Published 2023-03-31; 24:6069. URL: https://doi.org/10.3390/ijms24076069 (khakurel2023roleofgarp pages 7-9)
- Liu D, Zhou D, Sun Y, Zhu J, Ghoneim D, et al. A Transcriptome-Wide Association Study Identifies Candidate Susceptibility Genes for Pancreatic Cancer Risk. Cancer Research. Published 2020-10; 80:4346-4354. URL: https://doi.org/10.1158/0008-5472.CAN-20-1353 (liu2020atranscriptomewideassociation pages 6-8)

References

1. (liu2020atranscriptomewideassociation pages 6-8): Duo Liu, Dan Zhou, Yanfa Sun, Jingjing Zhu, Dalia Ghoneim, Chong Wu, Qizhi Yao, Eric R. Gamazon, Nancy J. Cox, and Lang Wu. A transcriptome-wide association study identifies candidate susceptibility genes for pancreatic cancer risk. Cancer Research, 80:4346-4354, Oct 2020. URL: https://doi.org/10.1158/0008-5472.can-20-1353, doi:10.1158/0008-5472.can-20-1353. This article has 43 citations and is from a highest quality peer-reviewed journal.

2. (sumya2024comprehensiveproteomiccharacterization pages 37-39): Farhana Taher Sumya, Walter S. Aragon-Ramirez, and Vladimir V. Lupashin. Comprehensive proteomic characterization of the intra-golgi trafficking intermediates. bioRxiv, Oct 2024. URL: https://doi.org/10.1101/2024.10.25.620336, doi:10.1101/2024.10.25.620336. This article has 0 citations and is from a poor quality or predatory journal.

3. (lai2024thesnareassociatedprotein pages 7-11): Chun-Chi Lai, Wan-Yun Chiu, Yan-Ting Chen, Chia-Lu Wu, and Fang-Jen S. Lee. The snare-associated protein sft2 functions in imh1-mediated snare recycling transport upon er stress. Molecular Biology of the Cell, Oct 2024. URL: https://doi.org/10.1091/mbc.e23-01-0019, doi:10.1091/mbc.e23-01-0019. This article has 0 citations and is from a domain leading peer-reviewed journal.

4. (khakurel2023roleofgarp pages 7-9): Amrita Khakurel and Vladimir V. Lupashin. Role of garp vesicle tethering complex in golgi physiology. International Journal of Molecular Sciences, 24:6069, Mar 2023. URL: https://doi.org/10.3390/ijms24076069, doi:10.3390/ijms24076069. This article has 18 citations and is from a poor quality or predatory journal.

5. (lai2024thesnareassociatedprotein pages 14-17): Chun-Chi Lai, Wan-Yun Chiu, Yan-Ting Chen, Chia-Lu Wu, and Fang-Jen S. Lee. The snare-associated protein sft2 functions in imh1-mediated snare recycling transport upon er stress. Molecular Biology of the Cell, Oct 2024. URL: https://doi.org/10.1091/mbc.e23-01-0019, doi:10.1091/mbc.e23-01-0019. This article has 0 citations and is from a domain leading peer-reviewed journal.

## Citations

1. liu2020atranscriptomewideassociation pages 6-8
2. lai2024thesnareassociatedprotein pages 7-11
3. khakurel2023roleofgarp pages 7-9
4. sumya2024comprehensiveproteomiccharacterization pages 37-39
5. lai2024thesnareassociatedprotein pages 14-17
6. https://doi.org/10.3390/ijms24076069
7. https://doi.org/10.1101/2024.10.25.620336
8. https://doi.org/10.1091/mbc.e23-01-0019
9. https://doi.org/10.1158/0008-5472.CAN-20-1353
10. https://doi.org/10.1091/mbc.e23-01-0019;
11. https://doi.org/10.1158/0008-5472.can-20-1353,
12. https://doi.org/10.1101/2024.10.25.620336,
13. https://doi.org/10.1091/mbc.e23-01-0019,
14. https://doi.org/10.3390/ijms24076069,